Home Details
| Official Symbol of Gene | B4GALT5 |
| Species | Homo sapiens |
| Entrez Gene ID | 9334 |
| Official Full Name | beta-1,4-galactosyltransferase 5 |
| Also known as | gt-V; B4Gal-T5; beta4Gal-T5; beta4GalT-V; BETA4-GALT-IV |
| Gene Type | protein coding |
| dbXrefs | Ensembl:ENSG00000158470 MIM:604016; AllianceGenome:HGNC:928 |
| Map Location | 20q13.13 |
| Detected Sample | brain |
| Sample Detail | N/A |
| Detected Method | qPCR |
| Disease | MS |
| Disease subtype | N/A |
| Population | N/A |
| Sample Size | lesions (n=10) / NAWM (n=5) / healthy controls (n=6) |
| Pubmed ID | 25216636 |
| Year | 2014 |
| Title | Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation |
| Expression | up-regulation |
| Risk type | Disease risk |
| Result | We found increased expression of B4GALT5 (2.15±0.28 fold) and B4GALT6 (8.26±2.11 fold) in MS lesions, but not in normal appearing white matter (NAWM) or controls |
| Mechanism/Pathway | The increased expression of B4GALT5/6 was linked to increased LacCer levels in MS lesions |

2023,CopyRight © HMU. College of Bioinformatics Science and Technology, Harbin, China.